GH Research to present GH001 depression trial data at ECNP 2026 meeting

GHRS•2026-10-09

GH Research plans three posters on its GH001 depression trials at ECNP 2026, with presentations scheduled for Oct. 11 in Munich; the announcement did not report results.

1. Posters scheduled

GH Research plc plans three posters featuring data from its GH001-TRD-201 and GH001-BD-202 trials at ECNP 2026. The presentations are scheduled for Poster Session 2 on Oct. 11 in Munich and will focus on treatment-resistant depression and bipolar depression; results have not yet been presented. An industry satellite symposium on rapid-acting antidepressants is scheduled for Oct. 10.

Sources

GH Research to present GH001 depression trial data at ECNP 2026 meeting

Sec

GH Research to present GH001 depression trial data at ECNP 2026 meeting

1. Posters scheduled

Related News

East West Bancorp: Truist Securities cuts target price to $131 from $137

French and Italian debt risk premiums set for weekly decline

Lessor Avolon orders 250 Boeing and Airbus jets, with option for 100 more

Sources

GH Research to present GH001 depression trial data at ECNP 2026 meeting

JPMorgan sets JPST monthly cash distribution at $0.07682 per unit

Ford Motor: Deutsche Bank cuts target price to $15 from $16